Patient reported toxicity and quality of life after hypofractionated high-dose intensity-modulated radiotherapy for intermediate- and high risk prostate cancer.

Treatment group was borderline significant (p = 0.51) For GI toxicity the significant variables on univariate analyses were: a Gleason score ≥ 7 (p = 0.050) and baseline symptoms of grade ≥ 1 GI toxicity (p = 0.021).

also in 11,409 other papers